| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.0M | +17.4% | +27.7% |
| Cost of Revenue | $571K | +9.2% | +34.7% |
| Gross Profit | $5.4M | +18.3% | +27.0% |
| R&D Expense | $1.4M | +2.1% | +18.2% |
| SG&A Expense | $3.8M | +7.9% | -5.1% |
| Operating Income | $238K | +179.9% | +126.2% |
| Pre-tax Income | $290K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.2M | -15.7% | +25.7% |
| Accounts Receivable | $6.3M | +134.8% | +86.2% |
| Current Assets | $14.5M | +19.4% | +50.3% |
| Total Assets | $25.3M | +9.5% | +22.1% |
| Current Liabilities | $6.3M | +25.5% | +60.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.1M | — | — |
| Capital Expenditures | $44K | — | — |
| Investing Cash Flow | -$254K | — | — |
| Financing Cash Flow | $664K | — | — |
| Free Cash Flow | $2.1M | — | — |
| +215.5% |
| +134.6% |
| Income Tax | $0 | — | — |
| Net Income | $290K | +215.5% | +134.6% |
| EPS (Basic) | $0.01 | +200.0% | +125.0% |
| EPS (Diluted) | $0.01 | +200.0% | +125.0% |
| $6.3M |
| +25.5% |
| +60.9% |
| Stockholders' Equity | $18.9M | +5.0% | +13.0% |